Manostaxx was at CPhI 2022 at Frankfurt with Somai Pharmaceuticals.
Michael Sassano, Founder, Chairman & CEO Somai Pharmaceuticals and Investor, Cannabis, GMP, Pharmaceutical &Herbal Medicine was present with George Bellow, Chief Operating Officer / CO-Founder at SOMAÍ Pharmaceuticals and Vasiliki Koutelieri, Country Director.
The Stand was full with meetings with Companies representatives:
Somai Pharmaceuticals is developing 41 products, some shown in the expositor:
Visit Somai Pharmaceuticals site: Somai Pharmaceuticals
